An interventional study of Dexcom G6 and SMBG or venous/arterial blood glucose in Cardiac Disease, PreDiabetes and Diabetes Mellitus, sponsored by Kangbuk Samsung Hospital. Recruiting at 1 site in Korea, Republic of. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-23.
Sponsored by Kangbuk Samsung Hospital · Not applicable, Interventional, and Treatment
The aim of this study is to assess the level of glycemic control and the incidence of surgery-related complications in cardiac patients post-surgery when Continuous Glucose Monitoring (CGM) is utilized, as compared to traditional methods of arterial/venous blood sampling and Point-of-Care Testing (POCT) for glucose monitoring.
2,135 studies on the registry are indexed under Heart Diseases; 252 are open to participants now.
This study's planned enrollment of 68 is below the median of 129 across 931 interventional studies indexed under Heart Diseases.
Browse Heart Diseases studies →Kangbuk Samsung Hospital is the lead sponsor of 63 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients with prediabetes
Exclusion Criteria:
Severe patients who are deemed difficult to continue research during surgery (excluded at the researcher's discretion)
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Glycemic control was monitored using CGM data for seven days following cardiac surgery
Device: Dexcom G6
Glycemic control was monitored using SMBG or venous/arterial glucose data for seven days following cardiac surgery
Device: SMBG or venous/arterial blood glucose
Glycemic control was monitored using CGM data for seven days following cardiac surgery
Glycemic control was monitored using SMBG or venous/arterial blood glucose data for seven days following cardiac surgery
Time within the target range of 100-180 mg/dL
Time within the target range of 100-180 mg/dL as assessed by CGM for 7 days after surgery
Time frame: 1-7 days after surgery
Time within the target range of 100-140 mg/dL
Time within the target range of 100-140 mg/dL as assessed by CGM for 7 days after surgery
Time frame: 1-7 days after surgery
Time within the target range of 70-180 mg/dL
Time within the target range of 70-180 mg/dL as assessed by CGM for 7 days after surgery
Time frame: 1-7 days after surgery
Time to reach <70 mg/dL
Time to reach \<70 mg/dL as assessed by CGM for 7 days after surgery
Time frame: 1-7 days after surgery
Time to reach <54 mg/dL
Time to reach \<54 mg/dL as assessed by CGM for 7 days after surgery
Time frame: 1-7 days after surgery
Time to reach >180 mg/dL
Time to reach \>180 mg/dL as assessed by CGM for 7 days after surgery
Time frame: 1-7 days after surgery
Time to reach >250 mg/dL
Time to reach \>250 mg/dL as assessed by CGM for 7 days after surgery
Time frame: 1-7 days after surgery
Standard Deviation (SD)
SD value evaluated by CGM for 7 days after surgery
Time frame: 1-7 days after surgery
Coefficient of variation (CV)
CV value evaluated by CGM for 7 days after surgery
Time frame: 1-7 days after surgery
Mean glucose
Mean glucose value evaluated by CGM for 7 days after surgery
Time frame: 1-7 days after surgery
Glucose management indicator (GMI)
GMI value evaluated by CGM for 7 days after surgery
Time frame: 1-7 days after surgery
Number of days of ICU hospitalization
Number of days of ICU hospitalization
Time frame: From 1 day after surgery until the date of ICU discharge or date of death from any cause, whichever came first, asessed up to 30 days
Number of days hospitalized after surgery
Number of days hospitalized after surgery
Time frame: From 1 day after surgery until the date of hospital discharge or date of death from any cause, whichever came first, asessed up to 30 days
Number of participants with pneumonia occurrence after surgery
Number of participants with pneumonia occurrence within 1 week after surgery
Time frame: 1-7 days after surgery
Number of participants with wound infection occurrence after surgery
Number of participants with wound infection occurrence within 1 week after surgery
Time frame: 1-7 days after surgery
Number of participants who underwent CRRT implementation after surgery
Number of participants who underwent CRRT implementation within 1 week after surgery
Time frame: 1-7 days after surgery
Number of participants with Atrial fibrillation occurrence after surgery
Number of participants with Atrial fibrillation occurrence within 1 week after surgery
Time frame: 1-7 days after surgery
Number of participants with symptomatic CVA (ischemic and hemorrhagic) occurrence after surgery
Number of participants with symptomatic CVA (ischemic and hemorrhagic) occurrence within 1 week after surgery
Time frame: 1-7 days after surgery
Changes in concentration of serum CRP level after surgery
Changes in concentration of serum CRP level after surgery (between baseline and peak value within 1 week after surgery)
Time frame: 1-7 days after surgery
Mortality within 30 days of surgery
Mortality within 30 days of surgery
Time frame: 1-30 days after surgery
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kangbuk Samsung Hospital